Humandiploidcellvirus
(HDCV) 469 – 470
Humangranulocyticehr-
lichiosis(HGE) 333
Humanherpesvirus 6
(HHV6) 41 8, 425
clinicalpicture 425
diagnosis 42 5, 650
epidemiology 425
pathogenesis 425
Humanherpesvirus 8
(HHV8) 41 8, 425 – 426
clinicalpicture 425 – 426
diagnosis 426
Humanimmunodeficiency
virus(HIV) 44 8, 451 – 455
clinicalpicture 451 – 453
diagnosis 44 8,453, 6 45,
648
HIVantibodydetec-
tion 453
HIVantigendetection
453
PCR 453
rapidHIVtest 453
epidemiology 454
genome 449 – 450
genesessentialtore-
plication 449
genesnotessentialto
replication 449
structuralgenes 44 9,
450
infection/immunere-
sponserelationship
104
pathogenesis 451 – 453
prevention 454
precautionsfor
healthcarestaff 455
replication 451
therapy 454 – 455
combinationtreat-
ments 455
viralloaddetermination
453
seealsoAIDS;Opportu-
nisticpathogens
Humanleukocyteantigen
(HLA)58, 59 , 141
Humanmonocyticehrli-
chiosis(HME) 333
Humanpapillomavirus
(HPV) 414
HumanT-cellleukemia
virus(HTLV) 44 8, 449
HTLVI 449
HTLVII 449
Humoral 141
defensefactors 22
immunity23, 48 – 50,
85 – 86, 402
cytotoxichumoralim-
muneresponses
109 – 113
Hyalohyphomycoses355,
369
Hyaluronidase 238
Hybridoma 69 , 141
HydatidcystseeEchino-
coccusgranulosus
Hydrolyticexoenzymes
15
Hymenolepisnana(hyme-
nolepiosis) 54 4, 575
clinicalmanifestations
575
diagnosis 575 , 640
lifecycle 575
occurrence 575
therapy 575
Hypersensitivityreactions
delayedtype(DTH)
9 8–9 9 , 11 4–1 15 , 140
IgE-triggeredanaphy-
laxis 108 – 109
seealsoImmunopathol-
ogy
Hyphae 349 – 350, 351
&I
Idiotype56, 141
IgA 49 – 51
functions 56
IgAprotease 15
IgD 4 9, 56
IgE 4 9, 51
functions56, 101
IgE-triggeredanaphy-
laxis 108 – 109
IgG 4 9, 51
functions 56
heavychainrearrange-
ment 54
subclasses 49
IgM 49 – 51 , 71 ,93, 94
detection 411
functions 56
Immunecomplexes
11 3–1 14 , 141
inthepresenceofanti-
bodyexcess 114
inthepresenceofanti-
genexcess 113 – 114
Immunedefects 117 – 118
Immunehydropsfetalis
112
Immuneparalysis 141
Immuneresponse(Ir)
genes 142
Immunity43, 141
adaptive(acquired) 43 ,
44
balancebetweenpro-
tectionandimmuno-
pathology 103 – 105
concomitant 553
defectsinimmunede-
fenses 24
evasionstrategies
12 – 1 5, 102 – 103
nonspecificimmunity
1 2–1 3
specificimmunity
1 3–1 5
humoral23, 48 – 50,
85 – 86, 402
immunizationinfluence
10 6–1 07
innate43, 44
primaryresponse 143
secondaryresponse 143
specific 23
transplantationimmu-
nity 115 – 117
graft-versus-host
(GVH)reaction
11 5–1 16 , 141
host-versus-graft
(HVG)reactions 11 6,
141
measurement 117
tumorimmunity
10 7–1 08
seealsoDefensemech-
anisms;Immunological
memory;Immuno-
pathology;Immuno-
regulation;specific
infections
Immunization 31 – 34
active 31 – 34 , 403
vaccinegroups 32
antiviralprotection
402 – 404
influenceonimmune
defenses 106 – 107
passive34, 403 – 404
recommendedimmuni-
zationschedule 33
rhesusimmunization
112
678 HHumandiploidcellvirus(HDCV)
All rights reserved. Usage subject to terms and conditions of license
Kayser, Medical Microbiology © 2005 Thieme
All rights reserved. Usage subject to terms and conditions of license.